These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6698083)

  • 41. [Intravesical instillation of bacillus Calmette-Guerin for superficial bladder carcinoma: study on significance of additional maintenance instillations of bacillus Calmette-Guerin].
    Yabusaki N; Komatsu H; Tago K; Yamada Y; Ueno A
    Nihon Hinyokika Gakkai Zasshi; 1991 Feb; 82(2):290-6. PubMed ID: 1904120
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
    Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
    Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serial multiple-site biopsies in patients with bladder cancer.
    Soloway MS; Murphy W; Rao MK; Cox C
    J Urol; 1978 Jul; 120(1):57-9. PubMed ID: 671606
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Dedifferentiated superficial bladder cancer with invasion of the lamina propria (pT1 GIII)].
    Flamm J
    Z Urol Nephrol; 1986 Sep; 79(9):511-6. PubMed ID: 3788301
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Random biopsy and recurrence risk in patients with bladder cancer].
    Yamada Y; Hayashi Y; Kohri K; Terao E; Hirao N; HoriH ; IwaiY ; Kato K; Ito T; Tawada T; Asaka H; Andou H; Kawai T; Ikeuchi T; Watanabe H
    Nihon Hinyokika Gakkai Zasshi; 1996 Jan; 87(1):61-6. PubMed ID: 8683895
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of 2004 and 1973 World Health Organization grading systems and their relationship to pathologic staging for predicting long-term prognosis in patients with urothelial carcinoma.
    Cao D; Vollmer RT; Luly J; Jain S; Roytman TM; Ferris CW; Hudson MA
    Urology; 2010 Sep; 76(3):593-9. PubMed ID: 20381131
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Motility-related protein 1 (MRP-1/CD9) expression in urothelial bladder carcinoma and its relation to tumor recurrence and progression.
    Mhawech P; Herrmann F; Coassin M; Guillou L; Iselin CE
    Cancer; 2003 Oct; 98(8):1649-57. PubMed ID: 14534881
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tissue polypeptide antigen in normal and neoplastic urinary bladder. Preliminary reports.
    Senatore S; Attolini A; Luccarelli S; Candita F; Trabucco M
    Oncology; 1987; 44(2):118-23. PubMed ID: 2437508
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The cell surface antigens of bladder washing specimens in patients with bladder tumors, a new approach.
    Sadoughi N; Rubenstone A; Mlsna J; Davidsohn I
    J Urol; 1980 Jan; 123(1):19-21. PubMed ID: 6985978
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinical evaluation of grade 3 superficial bladder cancer].
    Shinohara M; Inoue Y; Itakura H; Munakata A; Kinoshita K
    Nihon Hinyokika Gakkai Zasshi; 1996 Jun; 87(6):892-9. PubMed ID: 8753007
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical significance of interobserver differences in the staging and grading of superficial bladder cancer.
    Tosoni I; Wagner U; Sauter G; Egloff M; Knönagel H; Alund G; Bannwart F; Mihatsch MJ; Gasser TC; Maurer R
    BJU Int; 2000 Jan; 85(1):48-53. PubMed ID: 10619945
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [A clinical study of recurrence and progression of grade 3 superficial bladder tumor].
    Ikegami S; Tsuji A; Suzuki S; Sumitomo M; Kimura F; Asano T; Nakajima F; Hayakawa M
    Hinyokika Kiyo; 1999 May; 45(5):325-9. PubMed ID: 10410314
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Non-invasive urine tests in diagnosis and as prognostic markers for urinary bladder carcinoma. Comparison of the BTAstat and NMP 22 tests with immunocytology using monoclonal antibodies against Lewis X and 486p3/12].
    Friedrich MG; Hellstern A; Hautmann SH; Noldus I; Huland H
    Urologe A; 2003 Apr; 42(4):523-30. PubMed ID: 12715124
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of superficial bladder tumors: achievements and needs. The EORTC Genitourinary Group.
    Kurth KH; Bouffioux C; Sylvester R; van der Meijden AP; Oosterlinck W; Brausi M
    Eur Urol; 2000; 37 Suppl 3():1-9. PubMed ID: 10828681
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunopathologic analysis of human urinary bladder cancer. Characterization of two new antigens associated with low-grade superficial bladder tumors.
    Cordon-Cardo C; Wartinger DD; Melamed MR; Fair W; Fradet Y
    Am J Pathol; 1992 Feb; 140(2):375-85. PubMed ID: 1739131
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term outcome of patients with frequently recurrent non-muscle-invasive bladder carcinoma treated with one perioperative plus four weekly instillations of mitomycin C followed by monthly bacillus Calmette-Guérin (BCG) or alternating BCG and interferon-α2b instillations: prospective randomised FinnBladder-4 study.
    Järvinen R; Marttila T; Kaasinen E; Rintala E; Aaltomaa S; Kallio J; Liukkonen T; Puolakka VM; Seppänen M; Tuhkanen K; Vaarala M; Viitanen J; Boström PJ;
    Eur Urol; 2015 Oct; 68(4):611-7. PubMed ID: 25748117
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changes in mucosal immune cells of bladder tumor patient after BCG intravesical immunotherapy.
    Chang SG; Lee SJ; Huh JS; Lee JH
    Oncol Rep; 2001; 8(2):257-61. PubMed ID: 11182036
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial.
    Di Stasi SM; Valenti M; Verri C; Liberati E; Giurioli A; Leprini G; Masedu F; Ricci AR; Micali F; Vespasiani G
    Lancet Oncol; 2011 Sep; 12(9):871-9. PubMed ID: 21831711
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Tumor recurrence and grade and/or stage progression in low grade tumor. Analysis of 154 patients with superficial transitional cell carcinoma of the bladder].
    Fujimoto H; Tobisu K; Teshima S; Kishi K; Kakizoe T
    Nihon Hinyokika Gakkai Zasshi; 1993 Jun; 84(6):1013-8. PubMed ID: 8345718
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Iatrogenic tumor cell implantation in bladder cancer].
    Mack D; Rammal E; Jakse G
    Urologe A; 1988 Mar; 27(2):99-104. PubMed ID: 3376373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.